Adly Thebaud, MD
Psychiatry · Orange City, FLNPI 1629049770
Payments from drug & device makers
Across 597 payments — averaging $2571.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$410K
- Sage Therapeutics, LLC$211K
- Boehringer Ingelheim$209K
- Supernus Pharmaceuticals, Inc.$178K
- F. Hoffmann-la Roche AG$98K
- H. Lundbeck A S$92K
- plus $336K from 15 others
Across 49 payments — averaging $4200.55 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Otsuka Pharmaceutical Development & Commercialization, Inc.$128K
- Arbor Pharmaceuticals, Inc.$60K
- Teva Pharmaceuticals USA, Inc.$7K
- AbbVie$7K
- Supernus Pharmaceuticals, Inc.$2K
- Eli Lilly$1K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 188 | $410,451 |
| Sage Therapeutics, LLC | 69 | $211,160 |
| Boehringer Ingelheim | 11 | $209,432 |
| Supernus Pharmaceuticals, Inc. | 98 | $178,053 |
| F. Hoffmann-la Roche AG | 83 | $98,048 |
| H. Lundbeck A S | 18 | $92,274 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 2 | $91,317 |
| Eli Lilly | 14 | $62,806 |
| Janssen Research & Development, LLC | 15 | $61,352 |
| Pfizer | 47 | $38,905 |
| Sunovion Pharmaceuticals Inc. | 2 | $15,225 |
| Arbor Pharmaceuticals, Inc. | 1 | $14,743 |
| Eisai Inc. | 7 | $12,689 |
| Shire North American Group Inc | 7 | $10,035 |
| Boehringer Ingelheim Pharma GmbH & Co.kg | 3 | $8,477 |
| Biohaven Pharmaceuticals, Inc. | 8 | $7,661 |
| Teva Pharmaceuticals USA, Inc. | 5 | $4,880 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $2,953 |
| Mylan Specialty L.p. | 2 | $2,050 |
| Neurocrine Biosciences, Inc. | 14 | $1,779 |
| Dr.reddy's Laboratories,inc. | 1 | $1,068 |
How this compares
$1,535,359 in reported general payments places this provider in the 95th percentile of 2,059 psychiatry providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other psychiatry in Orange City
- Edwin GomezWeston$24.9M
- Rishi KakarTamarac$23.9M
- Peter VentreOakland Park$18.7M
- Jose GamezHialeah$14.8M
- John JoyceJacksonville$13.6M
- Silvia Silva-DulucMiami$11.7M
- Kelley WilsonTampa$11.1M
- Emilio Mantero-AtienzaMiami Beach$10.9M
- Patricia JunqueraMiami$10.8M
- Olga LapeyraLauderhill$10M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.